Le Duc Dat, Han Sanghee, Yu Jayeon, Ahn Jeongjun, Kim Chang-Kwon, Lee Mina
College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungangno, Suncheon, 57922, Jeonnam, South Korea.
College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungangno, Suncheon, 57922, Jeonnam, South Korea.
Phytochemistry. 2023 Jun;210:113649. doi: 10.1016/j.phytochem.2023.113649. Epub 2023 Mar 22.
Three undescribed iridoid glucosides and nine known compounds were isolated from Vitex rotundifolia L. f. Their structural elucidation was performed based on their spectroscopic data or acid hydrolysis followed by HPLC analysis and comparison of their NMR data with those reported in the literature. These iridoids were then evaluated for inflammatory effects through inhibition on NO production level in LPS-stimulated RAW264.7 cells. The active compounds, rotundifoliin C, isonishindacin A, agnuside, and eurostoside, were further investigated for their anti-inflammatory mechanisms of action on expression levels of iNOS and COX-2 proteins. In addition, V. rotundifolia fractions also significantly inhibited LPS-induced IL-8 production, with IC values ranging from 9.81 to 54.31 μg/mL. Rotundifoliin A, agnuside, VR-I (10-O-vanilloyl aucubin), and eurostoside showed inhibition rates of 55.5%, 94.6%, 55.6%, and 81.9% on IL-8 production at concentrations of 100 μM, respectively, compared to those of control without sample addition. The therapeutic properties of the plant might give rise to develop the functional products to treat inflammatory diseases.
从蔓荆(Vitex rotundifolia L. f.)中分离出三种未描述的环烯醚萜苷和九种已知化合物。基于它们的光谱数据或酸水解,随后进行HPLC分析,并将它们的核磁共振数据与文献报道的数据进行比较,对其结构进行了阐明。然后通过抑制脂多糖(LPS)刺激的RAW264.7细胞中一氧化氮(NO)的产生水平,对这些环烯醚萜进行炎症作用评估。对活性化合物蔓荆苷C、异紫花前胡苷A、女贞苷和欧洲夹竹桃苷元,进一步研究了它们对诱导型一氧化氮合酶(iNOS)和环氧化酶-2(COX-2)蛋白表达水平的抗炎作用机制。此外,蔓荆提取物也显著抑制LPS诱导的白细胞介素-8(IL-8)产生,IC值范围为9.81至54.31μg/mL。与未添加样品的对照相比,蔓荆苷A、女贞苷、VR-I(10-O-香草酰桃叶珊瑚苷)和欧洲夹竹桃苷元在100μM浓度下对IL-8产生的抑制率分别为55.5%、94.6%、55.6%和81.9%。该植物的治疗特性可能会促使开发治疗炎症性疾病的功能性产品。